Replies to post #140501 on Biotech Values

[jq1234]

ABT PILOT 11 total patients: SVR4 100%, SVR12 91%, SVR24 91%, SVR36 82%, no additional relapse for the 10 patients with SVR48, thus best would be 82%, worst 73%.